For the management of anemia, ribavirin dose reductions should be used (refer to the prescribing information for
ribavirin for its dose reduction guidelines). If
ribavirin dose reductions are inadequate, discontinuation of INCIVEK should be considered. If ribavirin is permanently discontinued for the management of anemia, INCIVEK must also be permanently discontinued. Ribavirin may be restarted per the dosing modification guidelines for ribavirin.